Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185945-13-000001
Filing Date
2013-07-30
Accepted
2013-07-30 12:27:59
Documents
1
Period of Report
2013-07-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6305
  Complete submission text file 0001185945-13-000001.txt   8060
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O AEOLUS PHARMACEUTICALS, INC. 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address
RALLIS CHRIS A (Reporting) CIK: 0001185945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 13994878